ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes.

Matthew R Weir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.